Feb 10, 2020 05:52AM

Feb 9, 2020 08:40PM

Dec 20, 2019 08:47AM

Dec 20, 2019 08:45AM

Dec 9, 2019 07:00AM

Nov 15, 2019 07:00AM

Nov 12, 2019 04:05PM Valeritas Announces Third Quarter 2019 Financial Results

Oct 29, 2019 07:00AM

Oct 24, 2019 07:00AM

Oct 21, 2019 07:06AM

Oct 21, 2019 07:00AM

Oct 15, 2019 07:00AM

Oct 10, 2019 07:00AM

Oct 8, 2019 07:00AM Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the World Congress of Neurology (WCN 2019)

Oct 3, 2019 07:00AM

Oct 2, 2019 07:12AM

Oct 2, 2019 07:00AM

Sep 26, 2019 09:31AM

Sep 24, 2019 07:00AM

Sep 19, 2019 07:00AM

Sep 17, 2019 07:00AM Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

Sep 12, 2019 07:00AM

Sep 3, 2019 07:00AM

Aug 29, 2019 04:05PM

Aug 15, 2019 07:03AM

Aug 15, 2019 07:00AM

Aug 8, 2019 04:05PM

Aug 5, 2019 07:11AM Valeritas (VLRX) Reports Positive Results from Preclinical Pharmacokinetic Study of Apomorphine (Apo) Subcutaneous Infusion Delivered via h-Patch Device

Aug 5, 2019 07:00AM

Jul 30, 2019 07:26AM

Jul 30, 2019 07:00AM

Jun 27, 2019 07:06AM

Jun 27, 2019 07:00AM

Aug 22, 2018 09:26AM

Sep 5, 2017 04:05PM Valeritas to Present Results of the Prospective Pragmatic Multicenter Clinical Trial of V-Go® Wearable Insulin Delivery Device to the European Diabetes Community

Jun 12, 2017 08:00AM

May 4, 2017 04:01PM

322,885 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All